美国亚裔心衰住院患者的医疗质量差异
本研究基于2015至2023年美国Get With The Guidelines-Heart Failure登记处824家医院的数据,比较亚裔各群体与非西班牙裔白人住院心衰患者的医疗质量。结果显示,部分亚裔群体在出院最佳药物治疗、住院时长和无缺陷照护方面存在差异,院内死亡率无显著差异。
要点
- 越南裔男性接受出院最佳药物治疗的几率低于非西班牙裔白人患者。
- 菲律宾裔女性无缺陷照护几率显著较低,提示出院教育与随访安排存在差距。
- 不同亚裔女性群体在住院时长超过4天和无缺陷照护方面存在显著异质性。
核心结论
- 美国亚裔心衰住院患者的医疗质量存在异质性,部分亚裔群体与非西班牙裔白人患者相比存在明显差距。
研究设计与样本
- 研究纳入2015至2023年Get With The Guidelines-Heart Failure登记处824家美国医院。
- 研究对象为7,261例明确亚裔群体的心衰住院患者和768,566例非西班牙裔白人患者。
- 亚裔群体包括印度裔、华裔、菲律宾裔、日裔、韩裔、越南裔和其他亚裔。
主要发现
- 越南裔男性患者出院时接受最佳药物治疗的调整后比值比为0.68(95% CI:0.47-1.00)。
- 越南裔男性患者住院时长超过4天的调整后比值比为0.68(95% CI:0.50-0.91)。
- 菲律宾裔女性患者住院时长超过4天的调整后比值比为0.66(95% CI:0.46-0.95)。
- 菲律宾裔女性患者无缺陷照护的调整后比值比为0.52(95% CI:0.34-0.82)。
- 各亚裔群体与非西班牙裔白人患者的院内死亡率无差异。
关键数值与推荐
- 最佳药物治疗定义为射血分数≤40%者使用血管紧张素转换酶抑制剂、血管紧张素II受体阻滞剂或血管紧张素受体-脑啡肽酶抑制剂之一,射血分数≤40%者使用β受体阻滞剂,射血分数≤35%者使用盐皮质激素受体拮抗剂。
- 无缺陷照护包括最佳药物治疗、随访预约和心衰教育。
- 住院时长超过4天被定义为较长住院时长。
临床怎么用
- 临床应关注特定亚裔群体在心衰出院药物优化和出院教育方面的差距。
- 菲律宾裔女性患者的无缺陷照护几率较低,建议加强出院随访安排和心衰教育。
- 越南裔男性患者的最佳药物治疗和较长住院时长几率均较低,需进一步评估其照护模式。
局限性
- 研究基于登记处数据,可能存在未测量的混杂因素。
- 亚裔各群体样本量较小,可能影响估计精度。
- 研究仅纳入参与质量改进项目的医院,结果的外推性可能受限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Heart failure (HF) incidence varies among U.S. Asian populations. OBJECTIVES: The goal of this study was to identify differences in quality of inpatient care among individual groups of Asian patients hospitalized with HF and compared with non-Hispanic White patients. METHODS: This study included 824 U.S. hospitals from the Get With The Guidelines-Heart Failure registry (2015-2023). It evaluated the odds of optimal medical therapy (OMT) (defined as an angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker or angiotensin receptor-neprilysin inhibitor for those with an ejection fraction [EF] ≤40%; a beta-blocker for those with an EF ≤40%; and mineralocorticoid receptor antagonist for those with an EF ≤35%) at discharge for HF with reduced EF, and length of stay (LOS) >4 days, defect-free care (OMT, follow-up visit scheduling, HF education) at discharge, and in-hospital mortality among patients with any EF. The study cohorts included Asian Indian, Chinese, Filipino, Japanese, Korean, Vietnamese, and Other Asian vs non-Hispanic White patients. RESULTS: Among 7,261 Asian patients with individual Asian group identified (mean age range 69.9-78.8 years; 41%-51% female) vs 768,566 non-Hispanic White patients (mean age 74.6 years; 47% female), the odds of receiving OMT were lower in Vietnamese male patients (adjusted OR [aOR]: 0.68; 95% CI: 0.47-1.00). The odds of longer LOS (>4 days) were lower in Vietnamese male patients (aOR: 0.68; 95% CI: 0.50-0.91) and Filipina female patients (aOR: 0.66; 95% CI: 0.46-0.95). The odds of defect-free care were lower in Filipina female patients (aOR: 0.52; 95% CI: 0.34-0.82). In-hospital mortality did not differ compared with non-Hispanic White patients. Among female Asian patients, there was significant heterogeneity in frequency of LOS >4 days and defect-free care across individual Asian groups. CONCLUSIONS: HF quality of care is heterogeneous, with substantial gaps in certain U.S. Asian groups compared with non-Hispanic White patients.
引用
- Huang, Huffman, Kandula, et al. Heart Failure Quality of Care Among Asian Patients in the United States. J Am Coll Cardiol. 2026. PMID: 41532945. doi:10.1016/j.jacc.2025.10.070
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。